Insulin syringe

More than 4 in 5 Americans are in favor of the government negotiating lower prescription drug prices, a fact which has helped encourage the Democrat’s agenda to cap medication costs. The effort has been dealt a blow after a provision seeking to put a $35 cap on private insurance insulin prices was removed from a Senate bill following Republican opposition.

According to The Washington Post, the provision was part of a larger package which needed at least 60 votes to pass. In the end, only 57 Senators voted in favor of the legislation: all 50 Democrats, as well as 7 Republicans, including Susan Collins of Maine and both Louisianan and Alaskan senators, according to CNN

Senator Patty Murray, a Washington Democrat who voted for the bill, says of its necessity, “The cost of insulin isn’t just out of control, it is devastating people,” according to The Washington Post.

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.